Radius Research – Algernon Pharmaceuticals (AGN) CEO Christopher J. Moreau: Business Update – Ifenprodil & DMT Trials

image of Radius Research logo

Algernon Pharmaceuticals (AGN) CEO Christopher J. Moreau: Business Update – Ifenprodil & DMT Trials

 

 

Business Update – Ifenprodil & DMT Trials CEO Christopher J. Moreau of Algernon Pharmaceuticals

Webinar was held on Tuesday, September 27, 2022.

Algernon is a drug repurposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off-label prescription writing. https://algernonpharmaceuticals.com/